(Q43506522)

24 November 2017

Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock (English)

1 reference

24 November 2017

0 references

1 reference

1 reference

antimicrobial peptide

1 reference

7

1 reference

24 November 2017

Barbara Skerlavaj

8

0 references

Federico Mocchegiani

object named as

Federico Mocchegiani

4

0 references

author name string

Andrea Giacometti

1

1 reference

24 November 2017

Oscar Cirioni

2

1 reference

24 November 2017

Roberto Ghiselli

3

1 reference

24 November 2017

Giuseppina D'Amato

5

1 reference

24 November 2017

Raffaella Circo

6

1 reference

24 November 2017

Carmela Silvestri

9

1 reference

24 November 2017

Vittorio Saba

10

1 reference

24 November 2017

Margherita Zanetti

11

1 reference

24 November 2017

Giorgio Scalise

12

1 reference

24 November 2017

language of work or name

English

0 references

publication date

16 October 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

24 November 2017

1 reference

24 November 2017

169

1 reference

24 November 2017

2

1 reference

24 November 2017

187-194

1 reference

The pathogenesis of sepsis

24 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Septic shock: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Current epidemiology of septic shock: the CUB-Réa Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Critical care medicine in AJRCCM 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Current understanding of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Novel therapies for sepsis: antiendotoxin therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Recent developments in the treatment of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Cationic peptides: effectors in innate immunity and novel antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Effect of mono-dose intraperitoneal cecropins in experimental septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Biology and clinical relevance of naturally occurring antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Bactericidal activity of mammalian cathelicidin-derived peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Cathelicidin peptides as candidates for a novel class of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

cDNA sequences of three sheep myeloid cathelicidins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

SMAP-29 has two LPS-binding sites and a central hinge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

Experimental models of gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-971OC

10.1164/RCCM.200307-971OC

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference